Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides a Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. RH
5. NVDA
6. SPY
7. DOL:CN
8. RKLB
9. NDAQ
10. CRM

Go back to Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides a Corporate Update
(NASDAQ: NRIX) Delayed: 17.86 --17.86 (-0%)
Previous Close $0.00    52 Week High $ 
Open $0.00    52 Week Low $ 
Day High $17.97    P/E N/A 
Day Low $16.88    EPS $ 
Volume 233,630